Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(
1
)
Home
|
Portfolio
|
Market Currents
|
Investing Ideas
|
Dividends & Income
|
ETFs
|
Macro View
|
ALERTS
|
PRO
Poonam A. Arora
Poonam A. Arora
Articles
(4)
StockTalks
(1)
Comments
(27)
Profile
24
Followers
0
Following
Send Message
Poonam A. Arora
Stop Following
Poonam A. Arora
ABOUT
Aside from covering healthcare stocks at several sell-side shops, I have been an active trader since 2006.
SNAPSHOT
Description:
Sell side analyst.
Trading frequency:
Weekly
Interests:
Stocks - long, Stocks - short
COMPANY
Currently, there is no company profile for Poonam A. Arora.
BLOG
Currently, there are no blog details for Poonam A. Arora.
Book
Currently, there are no book details for Poonam A. Arora.
LATEST STOCKTALK
more »
$
MDVN
Based on my analysis Xtandi revenues this year will beat analyst consensus of $213 million.
Mar 30, 2013
Latest Comments
more »
Results from the Emend stud...
on
Tesaro: Potential Nausea Benefit Or Lack Thereo...
You are right. Rolapitant w...
on
Tesaro: Potential Nausea Benefit Or Lack Thereo...
Let me break down for you h...
on
Medivation: Still A Long But With Limited Upside
Your comments are diverging...
on
Medivation: Still A Long But With Limited Upside
You are dead wrong. As per ...
on
Medivation: Still A Long But With Limited Upside
Latest comments on Poonam A.'s Articles
Chimera Research G...
on
Tesaro: Potential Nausea Benefit Or Lack Thereo...
Poonam A. Arora
on
Tesaro: Potential Nausea Benefit Or Lack Thereo...
Poonam A. Arora
on
Tesaro: Potential Nausea Benefit Or Lack Thereo...
Chimera Research G...
on
Tesaro: Potential Nausea Benefit Or Lack Thereo...
Chimera Research G...
on
Tesaro: Potential Nausea Benefit Or Lack Thereo...
LATEST ARTICLES & INSTAPOSTS
more »
Medivation: Still A Long But With Limited Upside
Ariad: Shares Overvalued On Fundamentals
Tesaro: Potential Nausea Benefit Or Lack Thereof Key To Valuation
Synta: Share Price Not Reflecting Ganetespib Value Proposition
